<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Recent studies suggest that <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cells (<z:chebi fb="11" ids="17437,53115">CSCs</z:chebi>) mediate chemoresistance, but interestingly, only a small percentage of cells in a resistant <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> are <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi>; this suggests that non-<z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> survive by other means </plain></SENT>
<SENT sid="1" pm="."><plain>We hypothesised that chemoresistant <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) cells generate soluble factors that enhance survival of chemonaive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Chemoresistant <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells were generated by serial passage in <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> (Ox cells) </plain></SENT>
<SENT sid="3" pm="."><plain>Conditioned media (CM) was collected from parental and <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>-resistant (OxR) cells </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells were treated with CM and growth and survival were assessed </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">Tumour growth</z:e> rates were determined in <z:mp ids='MP_0003815'>nude</z:mp> mice after cells were treated with CM </plain></SENT>
<SENT sid="6" pm="."><plain>Mass spectrometry (MS) identified proteins in CM </plain></SENT>
<SENT sid="7" pm="."><plain>Reverse phase protein microarray assays determined signalling effects of CM in parental cells </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: <z:chebi fb="0" ids="31941">Oxaliplatin</z:chebi>-resistant CM increased survival of chemo-naive cells </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="11" ids="17437,53115">CSC</z:chebi> CM also increased growth of parental cells </plain></SENT>
<SENT sid="10" pm="."><plain>Parental and OxR <z:e sem="disease" ids="C0026277,C1368354" disease_type="Neoplastic Process" abbrv="">mixed tumours</z:e> grew larger than <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> composed of parental or OxR cells alone </plain></SENT>
<SENT sid="11" pm="."><plain>Mass spectrometry detected unique survival-promoting factors in OxR CM compared with parental CM </plain></SENT>
<SENT sid="12" pm="."><plain>Cells treated with OxR CM demonstrated early phosphorylation of EGFR and MEK1, with later upregulation of total Akt .We identified progranulin as a potential mediator of chemoresistance </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSION: Chemoresistant <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells and <z:chebi fb="11" ids="17437,53115">CSCs</z:chebi> may promote resistance through soluble factors that mediate survival in otherwise chemosensitive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells </plain></SENT>
</text></document>